Oxygen for Relief of Dyspnoea in Mildly- or Non-hypoxaemic Patients with Cancer: a Systematic Review and Meta-analysis

Overview

Journal Br J Cancer

Specialty Oncology

Date 2008 Jan 10

PMID 18182991

Citations 37

Authors

H E Uronis

D C Currow

D C McCrory

G P Samsa

A P Abernethy

Affiliations

Soon will be listed here.

Abstract

The aim of this study was to determine the efficacy of palliative oxygen for relief of dyspnoea in cancer patients. MEDLINE and EMBASE were searched for randomised controlled trials, comparing oxygen and medical air in cancer patients not qualifying for home oxygen therapy. Abstracts were reviewed and studies were selected using Cochrane methodology. The included studies provided oxygen at rest or during a 6-min walk. The primary outcome was dyspnoea. Standardised mean differences (SMDs) were used to combine scores. Five studies were identified; one was excluded from meta-analysis due to data presentation. Individual patient data were obtained from the authors of the three of the four remaining studies (one each from England, Australia, and the United States). A total of 134 patients were included in the meta-analysis. Oxygen failed to improve dyspnoea in mildly- or non-hypoxaemic cancer patients (SMD=-0.09, 95% confidence interval -0.22 to 0.04; P=0.16). Results were stable to a sensitivity analysis, excluding studies requiring the use of imputed quantities. In this small meta-analysis, oxygen did not provide symptomatic benefit for cancer patients with refractory dyspnoea, who would not normally qualify for home oxygen therapy. Further study of the use of oxygen in this population is warranted given its widespread use.

Citing Articles

Focus on the Role of Non-Invasive Respiratory Support (NRS) during Palliative Care in Patients with Life-Limiting Respiratory Disease.

Spinazzola G, Ferrone G, Michi T, Torrini F, Postorino S, Sbaraglia F J Clin Med. 2024; 13(17).

PMID: 39274381 PMC: 11396473. DOI: 10.3390/jcm13175165.

Comparison of the Life-Sustaining Treatment, Cardiopulmonary Resuscitation, and Palliative Care Implementation Rates between Homebound Patients with Malignant and Nonmalignant Disease Who Died in an Acute Hospital Setting: A Single-Center....

Miura H, Goto Y Healthcare (Basel). 2024; 12(2).

PMID: 38255025 PMC: 10815562. DOI: 10.3390/healthcare12020136.

Can guidelines rein in oxygen use? A retrospective cross-sectional study using routinely collected data.

Talat U, Schmidtke K, Khanal S, Turner A, Vlaev I Int J Qual Health Care. 2023; 35(4).

PMID: 37728256 PMC: 10558040. DOI: 10.1093/intqhc/mzad073.

Current Management Options for Dyspnea in Cancer Patients.

Mori M, Miwa S, Ikari T, Kako J, Hasegawa T, Matsunuma R Curr Treat Options Oncol. 2023; 24(6):565-579.

PMID: 37037975 DOI: 10.1007/s11864-023-01081-4.

Impact of end-of-life respiratory modalities on quality of dying and death and symptom relief in patients with interstitial lung disease: a multicenter descriptive cross-sectional study.

Koyauchi T, Suzuki Y, Sato K, Hozumi H, Karayama M, Furuhashi K Respir Res. 2022; 23(1):79.

PMID: 35379240 PMC: 8981636. DOI: 10.1186/s12931-022-02004-x.

References

. Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease: a clinical trial. Nocturnal Oxygen Therapy Trial Group. Ann Intern Med. 1980; 93(3):391-8. DOI: 10.7326/0003-4819-93-3-391. View

Harver A, Mahler D, Schwartzstein R, Baird J . Descriptors of breathlessness in healthy individuals: distinct and separable constructs. Chest. 2000; 118(3):679-90. DOI: 10.1378/chest.118.3.679. View

Kvale P, Simoff M, Prakash U . Lung cancer. Palliative care. Chest. 2003; 123(1 Suppl):284S-311S. DOI: 10.1378/chest.123.1_suppl.284s. View

Abernethy A, Currow D, Frith P, Fazekas B, McHugh A, Bui C . Randomised, double blind, placebo controlled crossover trial of sustained release morphine for the management of refractory dyspnoea. BMJ. 2003; 327(7414):523-8. PMC: 192892. DOI: 10.1136/bmj.327.7414.523. View

Eaton T, Garrett J, Young P, Fergusson W, Kolbe J, Rudkin S . Ambulatory oxygen improves quality of life of COPD patients: a randomised controlled study. Eur Respir J. 2002; 20(2):306-12. DOI: 10.1183/09031936.02.00301002. View

Stringer E, McParland C, Hernandez P . Physician practices for prescribing supplemental oxygen in the palliative care setting. J Palliat Care. 2005; 20(4):303-7. View

Jensen L, Onyskiw J, Prasad N . Meta-analysis of arterial oxygen saturation monitoring by pulse oximetry in adults. Heart Lung. 1998; 27(6):387-408. DOI: 10.1016/s0147-9563(98)90086-3. View

Dickersin K, Scherer R, Lefebvre C . Identifying relevant studies for systematic reviews. BMJ. 1994; 309(6964):1286-91. PMC: 2541778. DOI: 10.1136/bmj.309.6964.1286. View

Simon P, Schwartzstein R, Weiss J, LaHive K, FENCL V, TEGHTSOONIAN M . Distinguishable sensations of breathlessness induced in normal volunteers. Am Rev Respir Dis. 1989; 140(4):1021-7. DOI: 10.1164/ajrccm/140.4.1021. View

10.

American Academy Of Hospice And Palliative Medicine D . PC-FACS May 2, 2022. J Pain Symptom Manage. 2022; 64(1):80-87. DOI: 10.1016/j.jpainsymman.2022.05.005. View

11.

Booth S, Wade R, Johnson M, Kite S, Swannick M, Anderson H . The use of oxygen in the palliation of breathlessness. A report of the expert working group of the Scientific Committee of the Association of Palliative Medicine. Respir Med. 2004; 98(1):66-77. DOI: 10.1016/j.rmed.2003.08.008. View

12.

Philip J, Gold M, Milner A, Di Iulio J, Miller B, Spruyt O . A randomized, double-blind, crossover trial of the effect of oxygen on dyspnea in patients with advanced cancer. J Pain Symptom Manage. 2006; 32(6):541-50. DOI: 10.1016/j.jpainsymman.2006.06.009. View

13.

Bruera E, Schmitz B, Pither J, Neumann C, Hanson J . The frequency and correlates of dyspnea in patients with advanced cancer. J Pain Symptom Manage. 2000; 19(5):357-62. DOI: 10.1016/s0885-3924(00)00126-3. View

14.

Bruera E, Schoeller T, MacEachern T . Symptomatic benefit of supplemental oxygen in hypoxemic patients with terminal cancer: the use of the N of 1 randomized controlled trial. J Pain Symptom Manage. 1992; 7(6):365-8. DOI: 10.1016/0885-3924(92)90091-u. View

15.

Jadad A, Moore R, Carroll D, Jenkinson C, Reynolds D, Gavaghan D . Assessing the quality of reports of randomized clinical trials: is blinding necessary?. Control Clin Trials. 1996; 17(1):1-12. DOI: 10.1016/0197-2456(95)00134-4. View

16.

Reuben D, Mor V . Dyspnea in terminally ill cancer patients. Chest. 1986; 89(2):234-6. DOI: 10.1378/chest.89.2.234. View

17.

. Long term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema. Report of the Medical Research Council Working Party. Lancet. 1981; 1(8222):681-6. View

18.

Ahmedzai S, Laude E, Robertson A, Troy G, Vora V . A double-blind, randomised, controlled Phase II trial of Heliox28 gas mixture in lung cancer patients with dyspnoea on exertion. Br J Cancer. 2004; 90(2):366-71. PMC: 2409543. DOI: 10.1038/sj.bjc.6601527. View

19.

Bruera E, Sweeney C, Willey J, Palmer J, Strasser F, Morice R . A randomized controlled trial of supplemental oxygen versus air in cancer patients with dyspnea. Palliat Med. 2003; 17(8):659-63. DOI: 10.1191/0269216303pm826oa. View

20.

Currow D, Fazekas B, Abernethy A . Oxygen use--patients define symptomatic benefit discerningly. J Pain Symptom Manage. 2007; 34(2):113-4. DOI: 10.1016/j.jpainsymman.2007.03.004. View